Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Festi

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
The American Journal of Gastroenterology|August 13, 1999
Long-term results with interferon therapy in chronic type B hepatitis: a prospective randomized trialG Mazzella, G Saracco, D Festi, et al.
Hepatology (Baltimore, Md.)|October 27, 1997
Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of CholelithiasisA F Attili, R Capocaccia, N Carulli, et al.
Haematologica|December 29, 1998
Ultrasound-guided core-needle biopsy is effective in the initial diagnosis of lymphoma patientsP L Zinzani, A Colecchia, D Festi, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|July 17, 1998
Gallbladder motility and gallstone formation in obese patients following very low calorie diets. Use it (fat) to lose it (well)D Festi, A Colecchia, M Orsini, et al.
Alimentary Pharmacology & Therapeutics|June 29, 2006
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosisF Azzaroli, A Colecchia, A Colecchi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 19, 2002
Improved liver tests and greater biliary enrichment with high dose ursodeoxycholic acid in early stage primary biliary cirrhosisE Roda, F Azzaroli, G Nigro, et al.
European Review for Medical and Pharmacological Sciences|June 6, 2015
The effects of alcohol on gastrointestinal tract, liver and pancreas: evidence-based suggestions for clinical managementA Federico, G Cotticelli, D Festi, et al.
Alimentary Pharmacology & Therapeutics|September 27, 2007
Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acidF Azzaroli, A Mennone, V Feletti, et al.
Journal of Viral Hepatitis|April 27, 2005
A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis CA Mangia, G L Ricci, M Persico, et al.
Hepatology (Baltimore, Md.)|March 7, 2001
Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothersG Mazzella, N Rizzo, F Azzaroli, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
The American Journal of Gastroenterology|August 13, 1999
Long-term results with interferon therapy in chronic type B hepatitis: a prospective randomized trialG Mazzella, G Saracco, D Festi, et al.
Hepatology (Baltimore, Md.)|October 27, 1997
Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of CholelithiasisA F Attili, R Capocaccia, N Carulli, et al.
Haematologica|December 29, 1998
Ultrasound-guided core-needle biopsy is effective in the initial diagnosis of lymphoma patientsP L Zinzani, A Colecchia, D Festi, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|July 17, 1998
Gallbladder motility and gallstone formation in obese patients following very low calorie diets. Use it (fat) to lose it (well)D Festi, A Colecchia, M Orsini, et al.
Alimentary Pharmacology & Therapeutics|June 29, 2006
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosisF Azzaroli, A Colecchia, A Colecchi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 19, 2002
Improved liver tests and greater biliary enrichment with high dose ursodeoxycholic acid in early stage primary biliary cirrhosisE Roda, F Azzaroli, G Nigro, et al.
European Review for Medical and Pharmacological Sciences|June 6, 2015
The effects of alcohol on gastrointestinal tract, liver and pancreas: evidence-based suggestions for clinical managementA Federico, G Cotticelli, D Festi, et al.
Alimentary Pharmacology & Therapeutics|September 27, 2007
Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acidF Azzaroli, A Mennone, V Feletti, et al.
Journal of Viral Hepatitis|April 27, 2005
A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis CA Mangia, G L Ricci, M Persico, et al.
Hepatology (Baltimore, Md.)|March 7, 2001
Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothersG Mazzella, N Rizzo, F Azzaroli, et al.
Pageof 11